TruScreen Continues Strong Sales Growth in Q3 FY2024

GENERAL
Thu, Jan 25 2024 08:39 am

NZX/ASX Announcement

25 January 2024

TruScreen Continues Strong Sales Growth in Q3 FY2024

Highlights

• Revenues YTD to 31 December 2023 USD $887,958.00 (NZD$1,465,131), a 34 % increase on prior year
• SUS unit sales exceeded total of last financial year, reaching 141,300 by 31 December 2023 (9 months)
• China continuing to be major contributor
• Zimbabwe tender won and invoiced for 10,800 SUS

Truscreen Group Limited (NZX/ASX: TRU) is pleased to report a 40% growth in sales of devices and a 22% growth in sales of Single Disposable Sensor (SUS) for the nine months to 31 December 2023, over the same period prior year.

The major contributor to this growth is China following recognition/endorsement of TruScreen in the major national Guidelines, by the Chinese Society of Colposcopy and Cervical Pathology (CSCCP), published in the July 2023 edition of CSCCP's journal and the recommendation in the prestigious Blue Book in China. A roadshow by the Company’s distributor, Siweixiangtai Tech Co. Ltd (SWXT), has generatedsupported this growth, resulting in installation of TruScreen technology in several new major hospitals.

The successful Zimbabwe screening program under the National Aids Council has screened a total of 14,000 women in Masvingo province to date. The program continues with planned TruScreen Ministry of Health evaluation in the coming months, and it is anticipated that the program will be expanded beyond Masvingo province in financial year 2025.

The CEO, Dr Beata Edling commented:
“I’m delighted to report on the Q3 FY2024 results. We congratulate our partner, SWXT, in achieving strong growth in China, building on the recognition of TruScreen in the guidelines. We continue to work closely with the National AIDS Council of Ministry of Health in Zimbabwe in advancing the successful point-of-care program in Masvingo Province. ”

This announcement has been approved by the Board.
Ends

For more information, visit www.truscreen.com or contact:

Dr Beata Edling
Chief Executive Officer
[email protected]
Guy Robertson
Chief Financial Officer
[email protected]


Announcement PDF


Markets News

Meridian thinking big after Crown's offer to co-invest
Markets

Meridian thinking big after Crown's offer to co-invest

Govt pledge the biggest change to investment settings since listing in 2013.

Finance

ANZ heads to court as select committee splits active litigation

ANZ NZ consumer-finance case rumbles on as $300m settlement still on offer.

ANZ heads to court as select committee splits active litigation
Markets Market Close

NZ sharemarket up 0.4% despite inflation report

The S&P/NZX 50 Index closed at 13,344.96, up 55.75 points or 0.42%.

Graham Skellern 20 Oct 2025
NZ sharemarket up 0.4% despite inflation report